Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12611000929909
Ethics application status
Approved
Date submitted
23/08/2011
Date registered
30/08/2011
Date last updated
4/12/2015
Type of registration
Retrospectively registered

Titles & IDs
Public title
A Randomized Controlled Trial (RCT) of Internet-based Treatment of Anxiety Symptoms in Older Adults
Scientific title
A randomised controlled trial of Internet based treatment for older adults comparing Immediate treatment vs. delayed treatment on symptoms of anxiety.
Secondary ID [1] 262897 0
Nil
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Anxiety 270628 0
Condition category
Condition code
Mental Health 270795 270795 0 0
Anxiety

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Participants will be randomly assigned to one of two groups: 1)an immediate treatment group, or; 2) a delayed waitlist control group (beginning 9 weeks after the immediate treatment group begin. Participants will receive access to an 8 week internet-based treatment program.All participants will have at least mild symptoms of anxiety (GAD-7 total score >7). All participants will complete 5 lessons of Internet based treatment about management of symptoms of anxiety and stress. One lesson will be completed every 7 to 10 days. Each lesson will take about 15 minutes to complete. Participants will also have access to summaries of each lesson, and will read anonymous stories about other people with anxiety, taking a further 20 minutes per week. All participants will also receive automatic emails and brief weekly (<10minutes week) supportive telephone calls from a clinical psychologist.

Study questionnaires will be administered at application, pre-treatment, post-treatment, at 3-months post-treatment. These will take about 20-30 minutes to complete. The treatment materials are based on the Wellbeing Program, which teaches evidence-based cognitive behavioural skills.
Intervention code [1] 269250 0
Treatment: Other
Intervention code [2] 269294 0
Behaviour
Comparator / control treatment
The delayed waitlist control goup (beginning the course 9 weeks after the immediate treatment group beings). This is a wait-list control group.
Control group
Active

Outcomes
Primary outcome [1] 279493 0
Anxiety is measured by the Generalised Anxiety Disorder 7 Item Scale (GAD-7).
Timepoint [1] 279493 0
Administered at pre-treatment, prior to each Lesson in the course, post-treatment, and at 3-months post-treatment
Primary outcome [2] 279494 0
Symptoms and severity of depression is measured by the Patient Health Questionnaire-9 (PHQ-9)
Timepoint [2] 279494 0
Administered at pre-treatment, prior to each Lesson in the course, post-treatment, and at 3-months post-treatment
Primary outcome [3] 279495 0
Symptoms and severity of depression is measured by the Geriatric Depression Scale (GDS)
Timepoint [3] 279495 0
Administered at pre-treatment, prior to each Lesson in the course, post-treatment, and at 3-months post-treatment
Secondary outcome [1] 287738 0
Depression, Anxiety and Stress is measured by the Depression, Anxiety, Stress Scale (21 item) (DASS-21).
Timepoint [1] 287738 0
Administered at pre-treatment, post-treatment, and at 3-months post-treatment.
Secondary outcome [2] 287739 0
Health status is measured by the European Quality of Life-5 Dimensions: 5 level version (EQ-5D-5L).
Timepoint [2] 287739 0
Administered at pre-treatment, post-treatment, and at 3-months post-treatment.
Secondary outcome [3] 287740 0
Health service use (Number of visits to different health professionals, impact of anxiety and depression on absenteeism and reduced productivity, and impact on any caregivers) is measured by the Service Use Quesionnaire (based on the Adult Service Use Schedule (AD-SUS, Byford et al., 2010)).
Timepoint [3] 287740 0
Administered at pre-treatment, post-treatment, and at 3-months post-treatment.
Secondary outcome [4] 287741 0
Neuroticism is measured by using the NEO-Five Factor Inventory (NEO-FFI) Neuroticism scale.
Timepoint [4] 287741 0
Administered at pre-treatment, post-treatment, and at 3-months post-treatment
Secondary outcome [5] 287742 0
Perception of cognitive health is measured by the Cognitive Failures Questionnaire (CFQ).
Timepoint [5] 287742 0
Administered at pre-treatment, post-treatment, and at 3-months post-treatment
Secondary outcome [6] 287743 0
Positive and adaptive behaviours are measured by the Things You Do Questionnaire (TYDQ)
Timepoint [6] 287743 0
Administered at pre-treatment, post-treatment, and at 3-months post-treatment

Eligibility
Key inclusion criteria
1. Resident of Australia
2. 60 years – 75 years of age
3. Have access to a computer, the Internet, and use of a printer
4. Not currently participating in CBT
5. Not using illicit drugs or consuming more than three standard drinks/day
6. Not currently experiencing a psychotic mental illness or severe symptoms of depression (defined as a total score >19 or responding >2 to Question 9 [suicidal ideation] on the PHQ-9)
7. Reports that they have been assessed by a GP or specialist to rule out a physical cause for their anxiety
8. A total score >7 on the GAD-7 (indicating at least mild symptoms of anxiety). Note that meeting diagnostic criteria for a formal anxiety disorder is NOT an inclusion criteria – instead, participants need to have elevated symptoms of anxiety as measured by the GAD-7
9. If taking medication for anxiety or depression, been taking the same dose for at least 1 month and not intend to change that dose during the course of the program
10. Prepared to provide name, phone number and address, and to provide the name and address of a local general practitioner
11. Prepared to provide informed consent
Minimum age
60 Years
Maximum age
75 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Severe depression (score of 20 or greater on PHQ-9)
2. Suicidal intent or plan
3. Scoring below cut-off on the GAD-7
4. Current substance abuse
5. Psychosis
6. Presenting problem not anxiety

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Participants apply online, and those who meet inclusion criteria are administered a telephone interview to identify psychiatric diagnoses using the Mini Neuropsychiatric Interview Schedule (MINI 5.0.0). Participants are then randomly allocated to one of the two groups. Allocation concealment will occur by providing allocation details for each successive participant in a sealed envelope, which recruitment staff are required to open serially.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Participants will be randomized using a list generated prior to the study via a software program (www.random.org), at another site, in another country. The list will then be transcribed and details transferred to sealed envelopes.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 269721 0
Charities/Societies/Foundations
Name [1] 269721 0
beyondblue
Country [1] 269721 0
Australia
Primary sponsor type
University
Name
Macquarie University
Address
Balaclava Road, North Ryde,
Macquarie University NSW 2109
Country
Australia
Secondary sponsor category [1] 268761 0
None
Name [1] 268761 0
Address [1] 268761 0
Country [1] 268761 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 271686 0
Macquarie University Human Research Ethics Committee
Ethics committee address [1] 271686 0
Ethics committee country [1] 271686 0
Australia
Date submitted for ethics approval [1] 271686 0
10/05/2011
Approval date [1] 271686 0
15/07/2011
Ethics approval number [1] 271686 0
5201100470

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 33062 0
Prof Nickolai Titov
Address 33062 0
Centre for Emotional Health, Macquarie University, Ryde, NSW, 2019
Country 33062 0
Australia
Phone 33062 0
+61 2 98509901
Fax 33062 0
Email 33062 0
Contact person for public queries
Name 16309 0
Associate Professor Nickolai Titov
Address 16309 0
Centre for Emotional Health, Macquarie University, Ryde, NSW, 2019
Country 16309 0
Australia
Phone 16309 0
+612 9850 9901
Fax 16309 0
+612 9850 8062
Email 16309 0
Contact person for scientific queries
Name 7237 0
Associate Professor Nickolai Titov
Address 7237 0
Centre for Emotional Health, Macquarie University, Ryde, NSW, 2019
Country 7237 0
Australia
Phone 7237 0
+612 9850 9901
Fax 7237 0
+612 9850 8062
Email 7237 0

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseClinical and Cost-Effectiveness of Therapist-Guided Internet-Delivered Cognitive Behavior Therapy for Older Adults With Symptoms of Anxiety: A Randomized Controlled Trial.2015https://dx.doi.org/10.1016/j.beth.2014.09.007
N.B. These documents automatically identified may not have been verified by the study sponsor.